Stereochemistry–activity relationship of orally active tetralin S1P agonist prodrugs
摘要:
Modifying FTY720, an immunosuppressant modulator, led to a new series of well phosphorylated tetralin analogs as potent S1P1 receptor agonists. The stereochemistry effect of tetralin ring was probed, and (-)(R)-2-amino-2-((S)-6-octyl-1,2,3,4-tetrahydronaphthalen-2-yl)propan-1-ol was identified as a good SphK2 substrate and potent S1P1 agonist with good oral bioavailability. (C) 2010 Elsevier Ltd. All rights reserved.
DOI:
10.1016/j.bmcl.2010.02.006
作为产物:
描述:
(R)-4-(6-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)-4-methyloxazolidin-2-one 在
Chiralpak IC (3 x 15 cm) 806271 作用下,
以
甲醇 、 异丙醇 为溶剂,
以99%的产率得到
Compounds that have agonist activity at one or more of the S1P receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can behave as agonists at S1P receptors.
Compounds that have agonist activity at one or more of the S1P receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can behave as agonists at S1P receptors.